ABCM U.S.: Nasdaq

    Abcam PLC ADR

    Back To Top
    Last Updated: Jul 29, 2021 4:00 p.m. EDT Delayed quote

    $ 18.67

    -0.09 -0.48%
    Previous Close
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 98.62K 65 Day Avg: 212.13K
    46% vs Avg
    18.57 Day Range 19.03
    17.14 52 Week Range 24.69

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABCM Overview


    5 Day
    • 3.38%
    1 Month
    • -5.13%
    3 Month
    • -11.85%
    • -13.36%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 9 Full Ratings

    Recent News

    • eLesor
    • Dow Jones
    • Other News
    • Press Releases

    New Strong Sell Stocks for July 29th

    on Zacks.com

    2 of the Safest Biotech Stocks You'll Find Today

    on Motley Fool

    Analysts’ Top Healthcare Picks: Abcam (ABCM)

    on SmarterAnalyst

    Morgan Stanley Initiates a Hold Rating on Abcam (ABCM)

    on SmarterAnalyst

    Analysts Are Bullish on These Healthcare Stocks: Abcam (ABCM)

    on SmarterAnalyst

    Leerink Partners Sticks to Its Buy Rating for Abcam (ABCM)

    on SmarterAnalyst

    Abcam PLC ADR

    Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.